Papers
12
Total Citations
1,516
H-Index
9
About
Dr. Emma Rossi is a pioneering gynecologic oncologist whose research has fundamentally reshaped the surgical management of endometrial cancer. Her primary focus lies at the intersection of minimally invasive surgery, sentinel lymph node mapping, and fluorescence imaging. Dr. Rossi’s most transformative contribution is her leadership of the landmark FIRES trial (904 citations), which provided the first robust, prospective evidence that sentinel lymph node biopsy is a safe and effective alternative to full lymphadenectomy for endometrial cancer staging—a practice that has since become a new standard of care. She is also a global authority on robotic-assisted fluorescence imaging, demonstrating in multiple high-impact studies (186 and 119 citations) how indocyanine green (ICG) can dramatically improve the detection of sentinel nodes. Her work extends to validating the oncologic safety of robotic surgery for high-grade endometrial cancer (109 citations) and defining the learning curve for sentinel node biopsy (32 citations). Beyond her research, Dr. Rossi is a dedicated educator, having developed and implemented the Society of Gynecologic Oncology’s robotic surgery training curriculum for fellows (11 citations), ensuring the next generation of surgeons is equipped with these advanced techniques.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8Sentinel Lymph Node Biopsy in Endometrial Cancer: a New Standard of Care?29 citations · 2017
- 9
- 10